News

Read the latest news and updates from The Pirbright Institute.

Go to main content

Filters

Filters

Enter keywords

Select virus

Select month

Select researcher

Featured news

Close up of the face of a pink pig with brown patches. Its head is resting on the straw

Rolling in the straw: Pigging out on enrichment at Pirbright

Find out how we keep our pigs engaged.

Researcher in a white lab coat, light blue gloves with a hair net and face mask stood in front of a trolley with plastic tubes on. The researcher is placing a small plastic box into a cabinet that is branded with Quantoom Biosciences Ntensify

CVIM partners Quantoom Biosciences to advance vaccine development

The Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) has teamed up with Quantoom Biosciences to advance mRNA and saRNA vaccine development. Based at The Pirbright Institute, CVIM is actively engaged in mRNA and saRNA vaccine research as part of its mission to accelerate the…

Latest news

pig lying in hay pirbright

Pirbright scientists help combat African swine fever - a disease with no vaccine

African swine fever (ASF) continues to spread throughout eastern and central Europe, and China has now recorded its first outbreak. China is home to over half the world’s pig population (around 500 million pigs) so any potential spread throughout China and neighbouring countries would be devastating…

Cells infected with African swine fever

23 February 2018

Advance in the hunt for African swine fever vaccine

Researchers from The Pirbright Institute have made a promising step forward by identifying key African swine fever virus (ASFV) proteins that induce immune responses in pigs. ASFV is an extremely severe and economically important disease of domestic pigs, which is usually fatal in pigs and wild boar…

African swine fever advance through Europe

The continued advance of African swine fever (ASF) through Eastern European countries has triggered concern amongst pig farmers and governing bodies. Defra has upgraded the threat to the UK from ‘very low’ to ‘low’ – meaning the risk is “rare but could occur” (EFSA terminology). This severe disease…